Capula Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Buy
3,400
+1,900
+127% +$169K ﹤0.01% 657
2025
Q4
$119K Sell
1,500
-1,100
-42% -$86.2K ﹤0.01% 688
2025
Q3
$208K Buy
2,600
+900
+53% +$76.8K ﹤0.01% 601
2025
Q2
$155K Sell
1,700
-2,600
-60% -$237K ﹤0.01% 430
2025
Q1
$403K Buy
+4,300
New +$385K ﹤0.01% 335
2021
Q4
Sell
-189,500
Closed -$14.2M 293
2021
Q3
$14.2M Buy
189,500
+168,200
+790% +$13.4M 0.18% 103
2021
Q2
$1.72M Buy
+21,300
New +$1.74M 0.03% 312
2020
Q2
Sell
-30,000
Closed -$1.99M 327
2020
Q1
$1.99M Hold
30,000
0.07% 256
2019
Q4
$2.06M Buy
+30,000
New +$2.05M 0.04% 252

Other funds holding CL

Capula Management's CL Position: Q1 2026 in Review

Capula Management reduced its Colgate-Palmolive (CL) stake by 94% in Q1 2026, selling an estimated $368K and leaving 243 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Capula Management first reported a position in CL in Q4 2019 and has held it in 10 quarters since. The position peaked at $4.6M in Q3 2021. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capula Management held 243 shares of Colgate-Palmolive worth $20.7K as of Q1 2026.
  • Capula Management sold 4,133 Colgate-Palmolive shares in Q1 2026, an estimated $368K.
  • Colgate-Palmolive made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1041 holding.
  • Capula Management first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 10 quarters since.
  • Capula Management's Colgate-Palmolive position peaked at $4.6M in Q3 2021.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.